Search All Resources
Starting a Harm Reduction Program at Cass Lake IHS | June 28, 2023
Type: Past Presentation
Audience: Clinical
Program: Hepatitis C
Keywords: #harm reduction #naloxone #primary care #sterile equipment #syringe
In this presentation, Whitney Dickson, PharmD, shares the story of Cass Lake Indian Health Service choosing to start a harm reduction program, how they started, their success', challenges and lessons learned integrating a program in their pharmacy.
Date added: 06/21/23
A National Initiative to Eliminate HCV in the United States | June 21, 2023
Type: Past Presentation
Audience: Clinical
Program: Hepatitis C
Keywords: #daa #direct acting antiviral #elimination #hcv
In this presentation Dr. Karla Thornton provides an update on the national initiative to eliminate HCV in the United States, including a background on the epidemiology of the the public health crisis, current barriers to getting hepatitis C treatment, examples ...
Date added: 06/16/23
Hepatitis C Direct Acting Antiviral Treatment Interruptions | June 7, 2023
Type: Past Presentation
Audience: Clinical
Program: Hepatitis C
Keywords: #daa #direct acting antiviral #hcv #missed doses #treatment interruption
In this presentation Dr. Karla Thornton discusses how to apply the guidance provided by the AASLD/IDSA on HCV DAA treatment interruptions, identify when patients should have DAA therapy continued vs when DAA therapy should be stopped, and also describes the ...
Date added: 06/5/23
Hepatitis B Testing and Serology Interpretation | May 24, 2023
In this presentation Dr. Karla Thornton discusses Hepatitis B Virus (HBV) and serology interpretation. Dr Thornton describes the global burden of HBV, HBV awareness, how to identify appropriate baseline serologies for HBV and how to correctly interpret serologic tests for ...
Date added: 05/18/23
Medication Management of Depression | May 17, 2023
In this presentation, Dr. Jasen Christensen, DO, discusses the range of antidepressants available, reasons to choose and reasons to avoid certain antidepressants, and reviews the importance of antidepressant treatment duration.
Date added: 05/17/23
State of Hep C 2023 | May 3, 2023
Type: Past Presentation
Audience: Clinical
Program: Hepatitis C
Keywords: #hcv #hepatitis c #insurance #prior authorization #restrictions
In this presentation, Dr. Richard Manch, MD, provides a comprehensive overview and update of the latest HCV Treatment Restrictions Data from all 50 state Medicaid programs. Hepatitis C is our nation’s deadliest bloodborne infectious disease, yet many state Medicaid programs ...
Date added: 04/30/23
HCV 101: Medications and Management | April 26, 2023
Type: Past Presentation Training
Audience: Clinical
Program: Hepatitis C
Keywords: #hcv #hcv cure #hcv treatment #hep c #hepatitis
In this training, Dr. Paulina Deming discusses treatment and management of patients with hepatitis C in primary care, including medications, approaches to treatment, medication interactions, and treatment monitoring.
Date added: 04/26/23
Supporting Pregnant and Parenting People Experiencing SUDs | April 19, 2023
Type: Past Presentation
Audience: Clinical Community
Program: Hepatitis C
Keywords: #parents #pregnancy #pregnant #substance use disorder #SUD #SUD treatment
In this series of presentation, Dr Sherry Daker, PharmD, MHA, Treatment and Recovery Co-Lead for the IHS National Committee on Heroin, Opioids & Pain Efforts, highlights best practices for supporting pregnant and parenting people, partners, and families experiencing substance use disorders. ...
Date added: 04/17/23
Diabetes and HCV | April 5, 2023
Type: Past Presentation
Audience: Clinical
Program: Hepatitis C
Keywords: #diabetes #dm #hcc #hcv and diabetes #hepatitis c #hepatocellular carcinoma #type 2 diabetes
In this presentation, Dr. Carol Greenlee, endocrinologist, discusses the relationship of diabetes, liver disease and HCV infection. Dr. Greenlee provides an overview of extra hepatic manifestations of HCV infection, HCV & insulin resistance, how HCV can potentially induce or aggravate ...
Date added: 04/3/23
Substance Use and Injecting Behaviors During and After Hepatitis C Treatment Among Persons Who Inject Drugs | March 22, 2023
Type: Past Presentation
Audience: Clinical
Program: Hepatitis C
Keywords: #cure #hcv #pwid #substance use
In this presentation, Kimberly Page, PhD, MPH, Professor of Epidemiology at The University of New Mexico, describes injection practices among people who inject drugs (PWID) before, during, and after HCV treatment with DAAs. Dr Page also examines whether sharing injecting ...
Date added: 03/20/23